You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ORAVIG Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oravig, and when can generic versions of Oravig launch?

Oravig is a drug marketed by Galt Pharms and is included in one NDA.

The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ORAVIG?
  • What are the global sales for ORAVIG?
  • What is Average Wholesale Price for ORAVIG?
Summary for ORAVIG
Drug patent expirations by year for ORAVIG
Drug Prices for ORAVIG

See drug prices for ORAVIG

Pharmacology for ORAVIG
Drug ClassAzole Antifungal

US Patents and Regulatory Information for ORAVIG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms ORAVIG miconazole TABLET;BUCCAL 022404-001 Apr 16, 2010 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ORAVIG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galt Pharms ORAVIG miconazole TABLET;BUCCAL 022404-001 Apr 16, 2010 ⤷  Sign Up ⤷  Sign Up
Galt Pharms ORAVIG miconazole TABLET;BUCCAL 022404-001 Apr 16, 2010 ⤷  Sign Up ⤷  Sign Up
Galt Pharms ORAVIG miconazole TABLET;BUCCAL 022404-001 Apr 16, 2010 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ORAVIG

See the table below for patents covering ORAVIG around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 1107516 ⤷  Sign Up
Denmark 1408911 ⤷  Sign Up
Denmark 1792610 ⤷  Sign Up
European Patent Office 1792610 Systèmes thérapeutiques bioadhésifs à libération prolongée (Sustained release bioadhesive therapeutic systems) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.